Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells

Oncogene

Volumn 23, Issue 36, 2004, Pages 6170-6174

  You, Liang ^a   He, Biao ^a   Xu, Zhidong ^a   Uematsu, Kazutsugu ^a   Mazieres, Julien ^a   Mikami, Iwao ^a   Reguart, Noemi ^a   Moody, Terry W ^b   Kitajewski, Jan ^c   McCormick, Frank ^a   Jablons, David M ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d Cancer Center   (United States)

Author keywords

Apoptosis; Lung cancer; Wnt signaling

Indexed keywords

BETA CATENIN; MONOCLONAL ANTIBODY; SMALL INTERFERING RNA; SURVIVIN; T CELL FACTOR PROTEIN; WNT PROTEIN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANTIBODIES, MONOCLONAL; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; HUMANS; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; WNT2 PROTEIN;

EID: 4344570800     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207844     Document Type: Article

References (38)

1. Bienz M and Clevers H. (2000). Cell, 103, 311-320.
2. Blasband A, Schryver B and Papkoff J. (1992). Oncogene, 7, 153-161.
3. Chai J, Du C, Wu JW, Kyin S, Wang X and Shi Y. (2000). Nature, 406, 855-862.
4. Chen S, Guttridge DC, You Z, Zhang Z, Fribley A, Mayo MW, Kitajewski J and Wang CY. (2001). J. Cell Biol., 152, 87-96.
5. Dale TC, Weber-Hall SJ, Smith K, Huguet EL, Jayatilake H, Gusterson BA, Shuttleworth G, O'Hare M and Harris AL. (1996). Cancer Res., 56, 4320-4323.
6. Dann CE, Hsieh JC, Rattner A, Sharma D, Nathans J and Leahy DJ. (2001). Nature, 412, 86-90.
7. Elbashir SM, Harborth J, Weber K and Tuschl T. (2002). Methods, 26, 199-213.
8. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW. (1998). Science, 281, 1509-1512.
9. Holcombe RF, Marsh JL, Waterman ML, Lin F, Milovanovic T and Truong T. (2002). Mol. Pathol., 55, 220-226.
10. Hsieh JC, Rattner A, Small wood PM and Nathans J. (1999). Proc. Natl. Acad. Sci. USA, 96, 3546-3551.
11. Huguet EL, McMahon JA, McMahon AP, Bicknell R and Harris AL. (1994). Cancer Res., 54, 2615-2621.
12. Ioannidis V, Beermann F, Clevers H and Held W. (2001). Nat. Immunol., 2, 691-697.
13. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ and Thun MJ. (2004). CA Cancer J. Clin., 54, 8-29.
14. Katoh M. (2001). Int. J. Oncol., 19, 1003-1007.
15. Kim PJ, Plescia J, Clevers H, Fearon ER and Altieri DC. (2003). Lancet, 362, 205-209.
16. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC and Altieri DC. (1998). Nature, 396, 580-584.
17. Minna JD, Roth JA and Gazdar AF. (2002). Cancer Cell, 1, 49-52.
18. Nusse R and Varmus HE. (1982). Cell, 31, 99-109.
19. Olie RA, Simoes-Wust AP, Baumann B, Leech SH, Fabbro D, Stahel RA and Zangemeister-Wittke U. (2000). Cancer Res., 60, 2805-2809.
20. Orford K, Orford CC and Byers SW. (1999). J. Cell Biol., 146, 855-868.
21. Peifer M and Polakis P. (2000). Science, 287, 1606-1609.
22. Pham K, Milovanovic T, Barr RJ, Truong T and Holcombe RF. (2003). Mol. Pathol., 56, 280-285.
23. Polakis P. (2000). Genes Dev., 14, 1837-1851.
24. Reya T, O'Riordan M, Okamura R, Devaney E, Willert K, Nusse R and Grosschedl R. (2000). Immunity, 13, 15-24.
25. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y and Nakamura Y. (2000). Nat. Genet., 24, 245-250.
26. Shih IM, Yu J, He TC, Vogelstein B and Kinzler KW. (2000). Cancer Res., 60, 1671-1676.
27. Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM and Kitajewski J. (1997). Cell Growth Differ., 8, 1349-1358.
28. Smith K, Bui TD, Poulsom R, Kaklamanis L, Williams G and Harris AL. (1999). Br. J. Cancer, 81, 496-502.
29. Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang Z and Alnemri ES. (2000). J. Biol. Chem., 275, 36152-36157.
30. Tetsu O and McCormick F. (1999). Nature, 398, 422-426.
31. Uematsu K, Kanazawa S, You L, He B, Xu Z, Li K, Peterlin BM, McCormick F and Jablons DM. (2003). Cancer Res., 63, 4547-4551.
32. Uthoff SM, Eichenberger MR, McAuliffe TL, Hamilton CJ and Galandiuk S. (2001). Mol. Carcinog., 31, 56-62.
33. Veeman MT, Axelrod JD and Moon RT. (2003). Dev. Cell. 5, 367-377.
34. Vider BZ, Zimber A, Chastre E, Prevot S, Gespach C, Estlein D, Wolloch Y, Tronick SR, Gazit A and Yaniv A. (1996). Oncogene, 12, 153-158.
35. Wang CY, Guttridge DC, Mayo MW and Baldwin Jr AS. (1999). Mol. Cell. Biol., 19, 5923-5929.
36. Wodarz A and Nusse R. (1998). Annu. Rev. Cell Dev. Biol., 14, 59-88.
37. You Z, Saims D, Chen S, Zhang Z, Guttridge DC, Guan KL, MacDougald OA, Brown AM, Evan G, Kitajewski J and Wang CY. (2002). J. Cell Biol., 157, 429-440.
38. Zhang T, Otevrel T, Gao Z, Ehrlich SM, Fields JZ and Boman BM. (2001). Cancer Res., 61, 8664-8667.